Palmoplantar pustulosis - Palmoplantar Pustuloz

https://en.wikipedia.org/wiki/Pustulosis_palmaris_et_plantaris

Palmoplantar Pustuloz (Palmoplantar pustulosis) se yon dèrmatoz pustular kwonik frekan (ki se, yon pustuloz oswa psoriasis pustular) lokalize sou pla men yo ak plant sèlman, ki karakterize istolojikman pa pustul intraepidermal plen ak netrofil. Itilizasyon retinoid sistemik poukont yo ak an konbinezon ak fotochimyoterapi pou amelyore sentòm palmoplantar pustuloz (palmoplantar pustulosis) .

○ Tretman
Oral acitretin efikas pou kalite psoriasis sa a.
#Acitretin

Plis enfomasyon ― Kreyòl ayisyen

Nan ka sa a, yo ka sispèk pompholyx tou.

Nan absans pustil, ègzema nan men yo ka konsidere tou kòm yon dyagnostik diferans.

Rechèch imaj

References

Palmoplantar Psoriasis 28846363

NIH

Palmoplantar psoriasis se yon kalite psoriasis ki sitou afekte po a sou pla men w ak plant. Li parèt tankou po epè ak swa sèk, anpoul, oswa yon konbinezon de tou de kalite.
Palmoplantar psoriasis is a variant of psoriasis that characteristically affects the skin of the palms and soles. It features hyperkeratotic, pustular, or mixed morphologies.

Tumor Necrosis Factor Inhibitors 29494032

NIH

Tumor necrosis factor (TNF)-alpha inhibitors, including etanercept (E), infliximab (I), adalimumab (A), certolizumab pegol (C), and golimumab (G), are biologic agents which are FDA-approved to treat ankylosing spondylitis (E, I, A, C, and G), Crohn disease (I, A and C), hidradenitis suppurativa (A), juvenile idiopathic arthritis (A), plaque psoriasis (E, I and A), polyarticular juvenile idiopathic arthritis (E), psoriatic arthritis (E, I, A, C, and G), rheumatoid arthritis (E, I, A, C, and G), ulcerative colitis (I, A and G), and uveitis (A).